Keebeck Wealth Management Buys New Holdings in Bristol Myers Squibb Company $BMY
MarketBeat
Keebeck Wealth Management purchased a new position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 16,581 shares of the biopharmaceutical company's stock, valued at approximately $955,0
NYSE:BMY